Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
10% Potassium Hydroxide vs Cryotherapy for Molluscum Contagiosum
NCT05897112Phase 1Completed
- Sponsor
- Combined Military Hospital Abbottabad
- Start
- Nov 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of potassium hydroxide in molluscum contagiosum (MC) (2 arms), sponsored by Combined Military Hospital Abbottabad. Primary endpoint: Clearance of Lesion at 12 weeks. Started Nov 2022; status: completed.
02
Drugs
potassium hydroxide
03
Conditions
molluscum contagiosum (MC)
Beyond the preview
Go deeper on NCT05897112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05897112.